Aubree Gordon

17.1k citations

110 papers · 4.8k indexed · 4 hit papers · h-index 37

Impact in

Infectious Diseases top 0.2%
- Viral Infections and Vectors
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Modeling and Simulation top 0.5%
- COVID-19 epidemiological studies

Papers in

Modeling and Simulation 23
- COVID-19 epidemiological studies 23
Infectious Diseases 68
- Viral Infections and Vectors 32
- SARS-CoV-2 and COVID-19 Research 28
- COVID-19 Clinical Research Studies 13

Co-authors: Eva Harris Ángel Balmaseda Guillermina Kuan Lionel Gresh Juan Carlos Mercado Leah C. Katzelnick M. Elizabeth Halloran Sergio Ojeda
Journals: Clinical Infectious Diseases (13 papers)PLoS neglected tropical diseases (9 papers)The Journal of Infectious Diseases (6 papers)Cell Reports (4 papers)Influenza and Other Respiratory Viruses (4 papers)
Partner nations: United States Nicaragua Rwanda

In The Last Decade

Aubree Gordon

109 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1 2024 · 80 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Cell Host & Microbe
2023 Nature
2022 Cell
2017 Science

Peers

Countries citing papers authored by Aubree Gordon

Since Specialization

Citations

This map shows the geographic impact of Aubree Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aubree Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aubree Gordon more than expected).

Fields of papers citing papers by Aubree Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aubree Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aubree Gordon. The network helps show where Aubree Gordon may publish in the future.

Co-authors

The 25 scholars most cited alongside Aubree Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aubree Gordon Line = papers co-authored together Aubree Gordon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants Cell Reports ·Ian A. Mellis, Madeline Wu, Shilu Tong, Anwar Mukammi Kulaib Alruwaili, Anthony Bowen, Qian Wang, Carmen Gherasim, Virginia Pierce, Jayesh Shah, Lawrence J. Purpura, Michael T. Yin, Aubree Gordon, Yicheng Guo, David D. Ho	2025	3
2	Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infections Nature Communications ·José Víctor Zambrana, Ian A. Mellis, Selma Fauziah Ruhiat, Hannah E. Maier, Timothy N. Diggs Shirley P. Dutton, Norbaya Sidek, Roger López, Susan V. Lynch, Miguel Plazaola, Nery Sánchez, Sergio Ojeda, 三村洋美, Guillermina Kuan, Qian Wang, Lihong Liu, B. Jecowska-Trzebiatowska, David D. Ho, Aubree Gordon	2025	0
3	Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1 Science Translational Medicine ·José Víctor Zambrana, Michael R. Line, Rosemary A. Aogo, Sandra Bos, Sonia Arguello, Karla González, Damaris Collado, Rebecca Cunniffe, Guillermina Kuan, Aubree Gordon, B. Jecowska-Trzebiatowska, Leah C. Katzelnick, Eva Harris	2024	26
4	Obesity Is Associated With Increased Pediatric Dengue Virus Infection and Disease: A 9-Year Cohort Study in Managua, Nicaragua Clinical Infectious Diseases ·Carla Aspe Vacarezza, Rachel A. Myers, J. Y., José Víctor Zambrana, Brenda López, Nery Sánchez, Aubree Gordon, Ángel Balmaseda, Guillermina Kuan, Eva Harris	2024	4
5	Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster Cell Reports Medicine ·Qian Wang, Ian A. Mellis, Yicheng Guo, Carmen Gherasim, Riccardo Valdez, Aubree Gordon, David D. Ho, Lihong Liu	2024	4
6	XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1 Cell Host & Microbe ·Qian Wang, Yicheng Guo, Anthony Bowen, Ian A. Mellis, Riccardo Valdez, Carmen Gherasim, Aubree Gordon, Lihong Liu, David D. Ho Hit paper breakdown →	2024	80
7	Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection The Journal of Infectious Diseases ·刘广普, Daniel Stadlbauer, Ángel Balmaseda, Guillermina Kuan, Roger López, Asliddin Fayzullaev, Sergio Ojeda, Nery Sánchez, Ridzwan Bin Che'Rus, Miguel Plazaola, Amy Hensley, Florian Krammer, Aubree Gordon	2024	2
8	Comparisons of Pediatric and Adult SARS-CoV-2-Specific Antibodies up to 6 Months after Infection, Vaccination, or Hybrid Immunity Journal of the Pediatric Infectious Diseases Society ·Y. Liu, Wesley A. Cheng, Xiaohua Chen, ADRIANO JOSE CORREIA, Lauren Turner, 桐山良一, Jaycee Jumarang, ススムトモオカ, R. Belahsen, Thomas Fabrizio, E. Kaitlynn Allen, Paul G. Thomas, Richard J. Webby, Aubree Gordon, Pia S. Pannaraj	2023	4
9	Effects of boosting and waning in highly exposed populations on dengue epidemic dynamics Science Translational Medicine ·Rosemary A. Aogo, José Víctor Zambrana, Nery Sánchez, Sergio Ojeda, Guillermina Kuan, Ángel Balmaseda, Aubree Gordon, Eva Harris, Leah C. Katzelnick	2023	12
10	Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 iScience ·Qian Wang, Zhiteng Li, Yicheng Guo, Ian A. Mellis, Sho Iketani, Michael Liu, Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Aubree Gordon, Lihong Liu, David D. Ho	2023	13
11	High Co-circulation of Influenza and Severe Acute Respiratory Syndrome Coronavirus 2 Open Forum Infectious Diseases ·John Kubale, Amy Hensley, Ángel Balmaseda, Cristhiam Cerpas, Saira Saborío, Sergio Ojeda, 正平裕亮, Nery Sánchez, Susan V. Lynch, محمد عبد الناصر الصداعي, Selma Fauziah Ruhiat, 美恵檜原, Roger López, Miguel Plazaola, Guillermina Kuan, Aubree Gordon	2022	5
12	Burden and seasonality of primary and secondary symptomatic common cold coronavirus infections in Nicaraguan children Influenza and Other Respiratory Viruses ·Amy Hensley, Ángel Balmaseda, Daniel W. Axelsen, Mayuri Patel, Sergio Ojeda, Andrew F. Brouwer, 龚德全, Shuwei Cai, Kevin Bakker, Nery Sánchez, Roger López, Guillermina Kuan, Aubree Gordon	2022	2
13	The Nicaraguan Pediatric Influenza Cohort Study, 2011–2019: Influenza Incidence, Seasonality, and Transmission Clinical Infectious Diseases ·Hannah E. Maier, Guillermina Kuan, Lionel Gresh, Gerardo Chowell, Kevin Bakker, Roger López, Nery Sánchez, Brenda López, Amy Schiller, Sergio Ojeda, Eva Harris, Ángel Balmaseda, Aubree Gordon	2022	5
14	Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua Influenza and Other Respiratory Viruses ·Kathryn P. Hacker, Guillermina Kuan, Daniel W. Axelsen, Gerardo Chowell, Mayuri Patel, Nery Sánchez, Roger López, Sergio Ojeda, Brenda López, Jarrod J. Mousa, Hannah E. Maier, Ángel Balmaseda, Aubree Gordon	2022	14
15	SARS‐CoV‐2 infection‐induced immunity and the duration of viral shedding: Results from a Nicaraguan household cohort study Influenza and Other Respiratory Viruses ·Hannah E. Maier, Miguel Plazaola, Roger López, Nery Sánchez, Saira Saborío, Sergio Ojeda, 正平裕亮, Guillermina Kuan, Ángel Balmaseda, Aubree Gordon	2022	7
16	Birth cohort relative to an influenza A virus’s antigenic cluster introduction drives patterns of children’s antibody titers PLoS Pathogens ·Andrew F. Brouwer, Ángel Balmaseda, Lionel Gresh, Mayuri Patel, Sergio Ojeda, Amy Schiller, Roger López, Richard J. Webby, Martha I. Nelson, Guillermina Kuan, Aubree Gordon	2022	5
17	Twelve-Month Longitudinal Serology in SARS-CoV-2 Naïve and Experienced Vaccine Recipients and Unvaccinated COVID-19-Infected Individuals Vaccines ·Xiaohua Chen, Wesley A. Cheng, R. Belahsen, Prajakta Margale, Lauren Turner, ADRIANO JOSE CORREIA, 桐山良一, J. L. De Jong, Jaycee Jumarang, ススムトモオカ, John Kubale, E. Kaitlynn Allen, Paul G. Thomas, Aubree Gordon, Pia S. Pannaraj	2022	9
18	SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children SHILAP Revista de lepidopterología ·Amy Hensley, John Kubale, Guillermina Kuan, Sergio Ojeda, Daniel W. Axelsen, Nery Sánchez, Miguel Plazaola, Rudy Verheyen, Roger López, Ángel Balmaseda, Aubree Gordon	2022	5
19	Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults Clinical Infectious Diseases ·Hannah E. Maier, Raffael Nachbagauer, Guillermina Kuan, Sophia Ng, Roger López, Nery Sánchez, Daniel Stadlbauer, Lionel Gresh, Amy Schiller, Arvind Rajabhathor, Sergio Ojeda, dikatakan menyimpang, Fatima Amanat, Ángel Balmaseda, Florian Krammer, Aubree Gordon	2019	64
20	Novel correlates of protection against pandemic H1N1 influenza A virus infection Nature Medicine ·Sophia Ng, Raffael Nachbagauer, Ángel Balmaseda, Daniel Stadlbauer, Sergio Ojeda, Mayuri Patel, Arvind Rajabhathor, Roger López, dikatakan menyimpang, Nery Sánchez, Fatima Amanat, Lionel Gresh, Guillermina Kuan, Florian Krammer, Aubree Gordon	2019	124

About Aubree Gordon

Aubree Gordon is a scholar working on Modeling and Simulation, Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health and Health, having authored 110 papers that have together received 4.8k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (44 papers), Respiratory viral infections research (42 papers), Mosquito-borne diseases and control (33 papers), Viral Infections and Vectors (32 papers), SARS-CoV-2 and COVID-19 Research (28 papers), COVID-19 epidemiological studies (23 papers), Malaria Research and Control (16 papers) and COVID-19 Clinical Research Studies (13 papers). The work is most often cited by research in Infectious Diseases (3.2k citations), Modeling and Simulation (460 citations), Public Health, Environmental and Occupational Health (2.2k citations), Epidemiology (1.3k citations) and Virology (84 citations). Aubree Gordon has collaborated with scholars based in United States, Nicaragua and Rwanda. Frequent co-authors include Eva Harris, Ángel Balmaseda, Guillermina Kuan, Lionel Gresh, Juan Carlos Mercado, Leah C. Katzelnick, M. Elizabeth Halloran, Sergio Ojeda, Nery Sánchez and Guillermina Kuan. Their work appears in journals such as Clinical Infectious Diseases, PLoS neglected tropical diseases, The Journal of Infectious Diseases, Cell Reports and Influenza and Other Respiratory Viruses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact